Crossmark

Protective effects of (4-(1,2,4-oxadiazol-5-yl)phenyl)-2-aminoacetamide derivatives to adjuvant-induced arthritis rats by regulating the NF-κB signaling pathway

Crossref DOI link: https://doi.org/10.1007/s10787-022-01081-0

Published Online: 2022-10-06

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liu, Tongtong

Zhu, Yanan

Chen, Shiming

Du, Jiyu

Xing, Siqi

Dong, Shuanghong

Xia, Jucheng

Li, Zeng https://orcid.org/0000-0002-4501-4102
Funding

Funding for this research was provided by:

Anhui Provincial Department of Science and Technology (2208085MH281)

Anhui Provincial Department of Education (KJ2021ZD0019, gxyq202006)
License Information

Text and Data Mining valid from 2022-10-06

Version of Record valid from 2022-10-06
More Information

Article History

Received: 4 June 2022

Accepted: 21 September 2022

First Online: 6 October 2022

Declarations

:

: The authors declare that they have no competing interests.

: All experiments complied with the Ethical Guidelines and recommendations of the International Association for the Study of Pain (IASP). This study was approved by the Animal Experimental Ethnics Committee of Anhui Medical University (the approval number: LLSC20211198, the date of approval Note: October 15, 2021).

Document is current

Any future updates will be listed below